Skip to content
The Policy VaultThe Policy Vault

CialisMedica

Benign prostatic hyperplasia

Initial criteria

  • Approve for 1 year if the patient meets one of the following (A or B):
  • A) Patient has tried an alpha-1 (α1) blocker; OR
  • B) Patient has tried a 5α-reductase inhibitor.

Approval duration

1 year